Fundz

Vitro Biopharma reported raising $993,000 in an initial SEC Form D filing, from an offering of $405,000

PRIVATEJan 23, 2023

Amount Raised

$993,000

$993,000 sold, per SEC Form D (first sale Jan 6, 2023)

Round Type

Seed

DenverBiotechnology

Quick answer

Vitro Biopharma raised $993,000 in a Seed round, dated January 6, 2023. Vitro Biopharma is based in Denver, Colorado, United States.

How much did Vitro Biopharma raise?
Vitro Biopharma raised $993,000 in a Seed round on January 6, 2023.
What does Vitro Biopharma do?
Vitro Biopharma is an innovative biotechnology company focused on developing Wharton's jelly-derived cell therapies and targeting autoimmune diseases and inflammatory disorders.
Where is Vitro Biopharma based and how big is it?
Vitro Biopharma is based in Denver, Colorado, United States.
Who are the decision-makers at Vitro Biopharma?
Fundz holds 1 contact at Vitro Biopharma, including the Executive Officer, Director. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Vitro Biopharma that raised within 45 days of this round, from Fundz verified event records.

  • Xolo raised $8.5M (Series A) on February 20, 2023.
  • NovAb raised $300K (Seed) on February 17, 2023.
  • Pathos AI raised $20M on February 17, 2023.
  • Evofem Biosciences raised $1.4M (Seed) on February 17, 2023.
  • Previa Medical raised $2.2M (Seed) on February 16, 2023.
  • 1606 Corp raised $20M (Funding Round) on February 16, 2023.

Who to call at Vitro Biopharma, and when

A new round usually means Vitro Biopharma is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Vitro Biopharma raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Vitro Biopharma, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Vitro Biopharma. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Vitro Biopharma

Location

4621 TECHNOLOGY DR.

Denver, Colorado, United States

About

Vitro Biopharma is an innovative biotechnology company focused on developing Wharton's jelly-derived cell therapies and targeting autoimmune diseases and inflammatory disorders. Our goal is to become a leader in developing differentiated product candidates in a rapid and efficient manner for the immunology and inflammatory market. AlloRx Stem Cell therapy is intended to be an “off-the-shelf” commercialized product that is stored frozen and available for on demand use. Our pipeline includes four core development programs. We intend to initiate our clinical trials for Long COVID and PTHS in late 2022 or 2023. In addition, we are also currently focused on our pre clinical development programs for MS and Lupus/SLE.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Vitro Biopharma raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsJim M., Executive Officer, DirectorSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Vitro Biopharma's next move

See what Strategic adds

Vitro Biopharma raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.